The advertisement promotes VYVGART Hyrtulo as the first and only self-injection treatment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), highlighting its quick administration time and providing important safety information.
Creative Information
| CID: | bcdd871d-6faf-4f59-bae3-3752dd65d7cf |
| CRID: | 29_616826346 |
| Domain: | vyvgart.com |
| Seat: | Xandr |
| Size: | 300x250 |
| Bid: | $0.27 |
| Timestamp: | 11/14/2025, 3:04:53 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 12/11/2025, 3:56:19 PM | 5.04s | |
| adomain_analysis | success | 12/11/2025, 3:59:27 PM | 4.05s | |
| adomain_capture | success | 12/11/2025, 3:59:23 PM | 0.19s | |
| ad_render | success | 12/11/2025, 3:56:14 PM | 30.98s | |
| brand_mapping | success | 12/11/2025, 3:51:43 PM | 0.12s | |
Analysis Results
Ad Format: banner
Brands: Vyvgart
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1434.73 KB | ||||||||||||||||||||||
| Render Time: | 9.14 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1434.89 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives
